July 31, 2014 7:02 AM ET

Pharmaceuticals

Company Overview of Altiris Therapeutics, Inc.

Key Executives for Altiris Therapeutics, Inc.

NameBoard RelationshipsTitleAge
Douglas H. Gooding 23 RelationshipsChief Executive Officer and President--
Dennis C. Liotta Ph.D.63 RelationshipsCo-founder, Chairman of Scientific Advisors and Director66
Hyunsuk Shim Ph.D.9 RelationshipsCo-Founder and Member of Scientific Advisors--
James P. Snyder Ph.D.19 RelationshipsCo-Founder and Member of Scientific Advisors--
Suzy Beckham Ph.D.No RelationshipsHead of Operations--

Altiris Therapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Bruce C. Robertson Ph.D. 129 RelationshipsH.I.G. BioVentures, LLC51
James P. Snyder Ph.D. 19 RelationshipsAltiris Therapeutics, Inc.--
Hyunsuk Shim Ph.D. 9 RelationshipsAltiris Therapeutics, Inc.--
Dennis C. Liotta Ph.D. 63 RelationshipsAltiris Therapeutics, Inc.66
Adrian Rawcliffe 57 RelationshipsHuman Genome Sciences Inc.--
View All Board Members

Altiris Therapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Advisory Board Ph.D.Dennis C. Liotta63 Relationships4 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
468.2K
Bonus
550.4K
Total Short Term Compensation
687.2K
Total Value of Options
17.6M
Compensation as of Fiscal Year
Altiris Therapeutics, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

PZ Cussons plc Reports Audited Consolidated Earnings Results for the Year Ended May 31, 2014; Recommends Final Dividend for the Year Ended May 31, 2014, Payable on October 1, 2014; Announces Board Changes
July 29, 2014 6:00 AM ET
ZIL Limited Announces Board Changes
July 24, 2014 5:34 PM ET
DBK Appoints Two New Partners to London Office
July 17, 2014 12:37 PM ET
Angelika Westerwelle Resigns as Managing Director of Karlie Group GmbH
July 10, 2014 2:08 PM ET
Harbinger Group Inc. Announces New Directors
July 08, 2014 9:12 PM ET

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Altiris Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.